Myopia Clinical Trial
Official title:
A 6-Hour Clinical Evaluation of New Daily-Wear Soft Contact Lenses
NCT number | NCT03235089 |
Other study ID # | CV-17-46 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 25, 2017 |
Est. completion date | August 3, 2017 |
Verified date | September 2020 |
Source | Coopervision, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 6 hours compared to nelfilcon A (control).
Status | Completed |
Enrollment | 31 |
Est. completion date | August 3, 2017 |
Est. primary completion date | August 3, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Is at least 18 years of age and has full legal capacity to volunteer - Has read, fully understood and signed the information consent letter - Currently wears or has previously worn soft contact lenses - Has spectacle cylinder =1.00D in both eyes. - Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes. - Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye. - Has clear corneas and no active ocular disease - Is willing and able to follow product usage instructions and maintain the visit schedule. Exclusion Criteria: - Has never worn contact lenses before - Has a systemic condition that in the opinion of the investigator may affect a study outcome variable - Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable - Has any known active ocular disease and/or infection - Has a monovision correction - Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses - Is aphakic - Has undergone corneal refractive surgery - Is pregnant or lactating, determined by self-report |
Country | Name | City | State |
---|---|---|---|
United States | Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University | Bloomington | Indiana |
Lead Sponsor | Collaborator |
---|---|
Coopervision, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Horizontal Lens Centration Assessed in Primary Gaze | Horizontal Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-nasal decentration given +ve value, temporal decentration given -ve value) | Baseline | |
Primary | Horizontal Lens Centration Assessed in Primary Gaze | Horizontal Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-nasal decentration given +ve value, temporal decentration given -ve value) | 6-hour | |
Primary | Vertical Lens Centration Assessed in Primary Gaze | Vertical Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-superior decentration given +ve value, inferior decentration given -ve value) | Baseline | |
Primary | Vertical Lens Centration Assessed in Primary Gaze | Vertical Lens Centration assessed in primary gaze was measured in 0.1mm steps. (mm-superior decentration given +ve value, inferior decentration given -ve value) | 6-hours | |
Primary | Lens Tightness Assessed by Push-up Test | Lens Tightness was assessed by Push-up test 1% steps: (0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement) | Baseline | |
Primary | Lens Tightness Assessed by Push-up Test | Lens Tightness was assessed by Push-up test 1% steps: (0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement) | 6-hours | |
Primary | Primary Gaze Lag Assessed Observing Lens Movement in Graticule | Primary gaze lag was assessed observing lens movement in graticule (0.1mm steps) | Baseline | |
Primary | Primary Gaze Lag Assessed Observing Lens Movement in Graticule | Primary gaze lag was assessed observing lens movement in graticule (0.1mm steps) | 6 hours | |
Primary | Horizontal Lens Lag Assessed Observing Lens Movement in Graticule | Horizontal lens lag was assessed observing lens movement in graticule (0.1mm steps) | Baseline | |
Primary | Horizontal Lens Lag Assessed Observing Lens Movement in Graticule | Horizontal lens lag was assessed observing lens movement in graticule (0.1mm steps) | 6 hours | |
Primary | Overall Lens Fit Acceptance | Overall lens fit acceptance based on lens fit alone (scale 0-4 in 0.25 steps: 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum) | Baseline | |
Primary | Overall Lens Fit Acceptance | Overall lens fit acceptance based on lens fit alone (scale 0-4 in 0.25 steps: 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=Optimum) | 6 hours | |
Primary | Up Gaze Lag Assessed Observing Lens Movement in Graticule | Up gaze lag was assessed observing lens movement in graticule (0.1mm steps) (The amount of lens drop in mm that occurs when the eye moves from primary gaze to up gaze). | Baseline | |
Primary | Up Gaze Lag Assessed Observing Lens Movement in Graticule | Up gaze lag was assessed observing lens movement in graticule (0.1mm steps) (The amount of lens drop in mm that occurs when the eye moves from primary gaze to up gaze). | 6 hours | |
Primary | Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink | Post-blink Movement was assessed by amount of movement (to the nearest 0.1mm) immediately after the blink | Baseline | |
Primary | Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink | Post-blink Movement was assessed by amount of movement (to the nearest 0.1mm) immediately after the blink | 6 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04923841 -
Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine
|
N/A | |
Active, not recruiting |
NCT04080128 -
Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control
|
N/A | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Completed |
NCT04604405 -
Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation
|
N/A | |
Recruiting |
NCT05594719 -
The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow
|
N/A | |
Completed |
NCT05594732 -
The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow
|
N/A | |
Completed |
NCT04492397 -
Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI)
|
N/A | |
Completed |
NCT04536571 -
Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses
|
N/A | |
Completed |
NCT06046209 -
Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens
|
N/A | |
Recruiting |
NCT06344572 -
Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia
|
Phase 3 | |
Recruiting |
NCT05611294 -
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
|
N/A | |
Completed |
NCT05656885 -
Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses
|
N/A | |
Active, not recruiting |
NCT05534022 -
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression.
|
N/A | |
Completed |
NCT03934788 -
the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens
|
N/A | |
Completed |
NCT03701516 -
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
|
N/A | |
Completed |
NCT05538754 -
Post-Market Evaluation of the EVO ICL
|
N/A | |
Completed |
NCT03139201 -
Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens
|
N/A | |
Completed |
NCT02555722 -
Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear
|
N/A | |
Not yet recruiting |
NCT06009458 -
Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear
|
N/A | |
Recruiting |
NCT05548478 -
Corneal Endothelial Cell Injury Induced by Mitomycin-C
|
N/A |